HK Stock Market Move | GUOQUAN(02517) surged over 4%, "GUOQUAN small wok" will conduct its first store trial operation next month.
Doughnut (02517) surges more than 4%, as of press time, up 4.27% to 3.66 Hong Kong dollars, with a turnover of 50.776 million Hong Kong dollars.
GUOQUAN (02517) rose more than 4%, up 4.27% as of the time of writing, trading at HK$3.66, with a turnover of HK$50.76 million.
In terms of news, on January 6, 2026, GUOQUAN Xiaochao will conduct its first trial operation. It is reported that the project is centered around intelligent cooking machines, combined with GUOQUAN's core advantages in compound seasonings and food supply chain, dedicated to providing LBX Pharmacy Chain Joint Stock with efficient and delicious freshly made Chinese food in community settings. Huaxi recently pointed out in a research report that the new format of "GUOQUAN Xiaochao" optimizes human labor through intelligent cooking machines to achieve standardization, and the product menu with various data analysis is most popular among consumers. After the model is proven successful, it is expected to become a new profit growth point for the company.
Related Articles

The subsidiary of Beijing Bohui Innovation Biotechnology Group (300318.SZ) has obtained the drug registration certificate for coagulation factor VIII.

Cybrid Technologies Inc. (603212.SH) intends to participate in private equity funds focusing on investments in the smart car and energy innovation sectors.

Gushengtang (02273) medical consortium network continues to expand, adding 13 more cooperative units by 2025 to accelerate the sinking of high-quality medical resources.
The subsidiary of Beijing Bohui Innovation Biotechnology Group (300318.SZ) has obtained the drug registration certificate for coagulation factor VIII.

Cybrid Technologies Inc. (603212.SH) intends to participate in private equity funds focusing on investments in the smart car and energy innovation sectors.

Gushengtang (02273) medical consortium network continues to expand, adding 13 more cooperative units by 2025 to accelerate the sinking of high-quality medical resources.

RECOMMEND





